lower abdominal pain glp 1 GLP-1 Medications Infographic Weight-Loss Medication Side Effects and

This leads to increased fullness, reduced appetite, and significant weight loss

A new paper in the journal Metabolism gives a detailed review of one of the more intriguing of these drugs, amycretin

All pretty positive stuff really ( Click here for a very good OPEN ACCESS review of the GLP-1-related Parkinsons research field)

Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naive T2D

Metabolism 164:156113 Linge J, Birkenfeld AL, Neeland IJ (2024) Muscle mass and Glucagon-Like Peptide-1 receptor agonists: adaptive or maladaptive response to weight loss

Approved in November 2023, Zepbound is a dual agonist targeting both GLP-1 and GIP receptors